Press Room

 

CAPD Statement on Energy & Commerce Health Subcommittee Markup of Drug Pricing Bills

We are encouraged to see today’s Congressional action to address our nation’s skyrocketing prescription drug prices and support greater access…

CAPD Statement on CBO Data on Medicare and Medicaid Drug Spending

Last week, the Congressional Budget Office (CBO) released a new report that shines a light on how the…

CAPD Statement on House E&C Health Subcommittee Hearing on Reducing Barriers to Market Competition

We applaud Congress’ efforts to identify specific policy solutions that aim to ease the burden of unsustainable drug…

CAPD Statement for the Record: House Ways & Means Subcommittee on Health

The Coalition for Affordable Prescription Drugs (CAPD) appreciates the opportunity to submit the following statement for the record…

CAPD Statement for the Record: Senate Aging Committee

The Coalition for Affordable Prescription Drugs (CAPD) appreciates the opportunity to submit the following statement for the record…

CAPD Statement for the Record: Senate Committee on Finance

The Coalition for Affordable Prescription Drugs (CAPD) appreciates the opportunity to submit the following statement for the record…

CAPD Statement on Proposed Rule to Eliminate Safe Harbor Protections for Rebates

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs (CAPD), issued the following statement in response…

CAPD Statement on FDA Efforts to Increase Transparency, Competition in Generic Drugs and Biosimilars

Debra Barrett, Executive Director of the Coalition for Affordable Prescription Drugs (CAPD), today issued the following statement in…